Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

TARS

Rang în acțiuni #4599
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Preț acțiune
$71.43
Capitalizare de piață
$3.34B
Schimbare (1 zi)
2.78%
Schimbare (1 an)
0.34%
Țară
US
Tranzacționează Tarsus Pharmaceuticals, Inc. (TARS)

Categorie

Healthcare
Raport P/S pentru Tarsus Pharmaceuticals, Inc. (TARS)
Raport P/S la data de October 2026 TTM: 5.13
Conform celor mai recente rapoarte financiare și prețului acțiunilor Tarsus Pharmaceuticals, Inc., raportul P/S actual (TTM) este 5.13. La sfârșitul anului 2023, compania avea un P/S de 34.10.
Istoricul raportului P/S pentru Tarsus Pharmaceuticals, Inc. din 2018 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 5.13 -54.93%
2024 11.38 -66.63%
2023 34.10 143.94%
2022 13.98 72.40%
2021 8.11 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.02 95.38%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
40.55 690.54%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.96 -22.78%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.15 97.80%
NL